Generic Product List For BE Studies

User Rating: 4 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive
 

 

 
Documents PDF Updated
1st Generic Immediate Release Product List Download Mar-17
2nd Generic Immediate Release Product List Download Mar-17
3rd Generic Immediate Release Product List Download Mar-17
4th Generic Immediate Release Product List Download Mar-17
5th Generic Immediate Release Product List Download Mar-19
6th Generic Immediate Release Product List Download Aug-18
7th Generic Immediate Release Product List Download July-19
8th Generic Immediate Release Product List Download Aug-17
9th Generic Immediate Release Product List Aug-18
Bioequivalence Requirements According to 1st - 9th List (Active Ingredients arranged in alphabetical orders) Download Dec-11
List of Comparator Products For Bioequivalence Studies Download July-19
List of Comparator Products For Fixed Dose Combination Download July-19
The Implementation on Antiviral (ARV) Drug Download Aug-18
List of Comparator Products in Dosage Forms of Effervescents, Dispersible, Orodispersible, Sublingual, Lozenges, Buccal and Chewable Tablets/Capsules Download Mar-19
Product containing combination of amino acid Download Apr-14
Comparative Dissolution Profile (CDP) Between Generic Product and Comparator Product with Gastro-Resistance Formulation Download Jun-16
3 Ways and 4 Ways Bioequivalence Studies Design Aug-09
Buletin Ubat-Ubatan - April 2003 (ARV Drug) Download Apr-03
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Monday 15 July 2019, 15:00:38.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language